Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Inner Mongolia Grand Pharmaceutical Co Days Inventory?
Inner Mongolia Grand Pharmaceutical CoBJSE:920433 70 Days Inventory is 513.98 as of Jun. 2026, which is 74% above its 10-year median of 295.26. GuruFocus rates BJSE:920433 with a GF Score™ of 70/100 and a GF Value™ of ¥3.89 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 918 Drug Manufacturers companies, Inner Mongolia Grand Pharmaceutical Co ranks worse than 90.96% on this metric.
BJSE:920433's Days Inventory is ranked worse than 90.96% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.655
vs BJSE:920433: 358.17
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inner Mongolia Grand Pharmaceutical Co's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.18.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Inner Mongolia Grand Pharmaceutical Co's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 3.22.
Inner Mongolia Grand Pharmaceutical Co (BJSE:920433) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Inner Mongolia Grand Pharmaceutical Co's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Inner Mongolia Grand Pharmaceutical Co's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Inner Mongolia Grand Pharmaceutical Co Days Inventory Related Terms
Inner Mongolia Grand Pharmaceutical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inner Mongolia Grand Pharmaceutical Co Days Inventory Chart
Inner Mongolia Grand Pharmaceutical Co Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Inner Mongolia Grand Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inner Mongolia Grand Pharmaceutical Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Inner Mongolia Grand Pharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Inner Mongolia Grand Pharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inner Mongolia Grand Pharmaceutical Co (BJSE:920433) has a Days Inventory of 513.98 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Inner Mongolia Grand Pharmaceutical Co and its competitors. This is 74% above median its historical median of 295.26. Over the past decade, Inner Mongolia Grand Pharmaceutical Co's Days Inventory has ranged from 171.08 to 434.93. According to the industry distribution chart, Inner Mongolia Grand Pharmaceutical Co ranks #835 out of 918 companies in the Drug Manufacturers industry, placing it in the top 91%.
Is Inner Mongolia Grand Pharmaceutical Co's Days Inventory too high?
Inner Mongolia Grand Pharmaceutical Co's current Days Inventory of 513.98 is 74% above median its 10-year median of 295.26. Over the past 10 years, this metric has ranged from a low of 171.08 to a high of 434.93. The Drug Manufacturers industry median Days Inventory is 164.66. Inner Mongolia Grand Pharmaceutical Co's value of 513.98 is 212.2% above this industry median. Based on the distribution chart, Inner Mongolia Grand Pharmaceutical Co ranks #835 out of 918 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Inner Mongolia Grand Pharmaceutical Co has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Inner Mongolia Grand Pharmaceutical Co's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Inner Mongolia Grand Pharmaceutical Co ranks #835 out of 918 companies for Days Inventory. This places Inner Mongolia Grand Pharmaceutical Co in the lower half of its industry. The industry median Days Inventory is 164.66. Inner Mongolia Grand Pharmaceutical Co's value of 513.98 is 212.2% above this benchmark. Historically, Inner Mongolia Grand Pharmaceutical Co's own Days Inventory has ranged from 171.08 to 434.93 over the past decade. While the company's 10-year median is 295.26 vs. the industry median of 164.66, Inner Mongolia Grand Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.66, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inner Mongolia Grand Pharmaceutical Co's current Days Inventory of 513.98 is 212.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Inner Mongolia Grand Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inner Mongolia Grand Pharmaceutical Co's current Days Inventory is 513.98, which is 74% above median its own 10-year median of 295.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inner Mongolia Grand Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Inner Mongolia Grand Pharmaceutical Co (BJSE:920433) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥3.89, compared to a current price of ¥4.94 — trading 27% above its estimated fair value. The current Days Inventory is 513.98, which is 74% above median its 10-year median of 295.26 and 212.2% above the Drug Manufacturers industry median of 164.66. Inner Mongolia Grand Pharmaceutical Co's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Inner Mongolia Grand Pharmaceutical Co (BJSE:920433), the current Days Inventory is 513.98 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inner Mongolia Grand Pharmaceutical Co (BJSE:920433) Overvalued in 2026?
Based on GuruFocus' analysis, Inner Mongolia Grand Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥4.94 is trading 27% above its estimated GF Value™ of ¥3.89.
GuruFocus considers Inner Mongolia Grand Pharmaceutical Co to be Modestly Overvalued.
Key valuation signals for BJSE:920433:
Days Inventory: 513.98 (74% above median its 10-year median of 295.26)
GF Value™: ¥3.89 vs. price of ¥4.94 (27% above fair value)
Industry Position: 212.2% above the Drug Manufacturers median (#835 of 918)
No single metric tells the full story. See the BJSE:920433 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inner Mongolia Grand Pharmaceutical Co Ltd is a pharmaceutical enterprise integrating the development of Mongolian medicine resources. It engages in the research and development, production, and sales of specialty medicines and general health products. The company's main business is the research and development, production of Chinese patent medicines (including ethnic medicines) and chemical preparations, and sales.
70GF Score
Get the complete analysis for BJSE:920433
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920433 has been successfully added to your 
